Search clinical trials for: Levonorgestrel IUS (Mirena, BAY86-5028)

Total 162 results

Bayer

Completed

Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)

Contraception

Sweden, Finland, Hungary, Norway, United Kingdom
Bayer

Completed

Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion (POST)

Contraception

China
Bayer

Completed

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea (J-MIRAI)

Menorrhagia, Dysmenorrhea

Japan
Bayer

Completed

Mirena in Idiopathic Menorrhagia

Idiopathic Menorrhagia

Croatia, Saudi Arabia, Bulgaria, Jordan, Romania, Russian Federation, Turkey, United Arab Emirates, Kuwait, India, Pakistan, Serbia, Sri Lanka
Bayer

Completed

Mirena Post-marketing Surveillance in Japan

Contraception

Japan
Bayer

Completed

Mirena Extension Trial (MET)

Contraception

United States
Bayer

Completed

Acceptability of Long-term Progestin-only Contraception in Europe

Contraception

Slovakia, France, United Kingdom, Ireland
Bayer

Completed

Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice (MARILIA)

Female Contraception

Algeria
Bayer
University of Utah

Completed

Duration of Use of Highly Effective Reversible Contraception

Pregnancy

United States
Bayer

Completed

Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding

Menorrhagia

Italy
Bayer

Completed

Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction (Mirabel)

Contraception

Russian Federation
Bayer

Completed

Mirena Observational Program

Endometrial Hyperplasia | Contraception | Menorrhagia | Estrogen Replacement Therapy

Kazakhstan
Bayer

Completed

GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China

Contraception

China, Korea, Republic of, Australia
Bayer

Completed

Scandinavian Mirena Insertion Nulliparous Trial.

Nulliparous

Sweden
Bayer

Completed

LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study

Contraception

Belgium, United States, Russian Federation, Germany, Austria
Bayer

Completed

Mirena Efficiency and Tolerability During the First Year of Use

Contraception | Medicated Intrauterine Devices

France
Bayer

Completed

Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)

Menorrhagia

United States, Canada, Brazil, Mexico, Argentina
Oregon Health and Science University
Society of Family Planning

Terminated

Early Postpartum Intrauterine Device (IUD) Placement

Contraception

United States
Bayer

Completed

Mirena or Conventional Medical Treatment for Menorrhagia

Menorrhagia

China, Indonesia, Korea, Republic of, Malaysia, Thailand, Taiwan, Hong Kong, Pakistan
Bayer

Completed

Cross -Over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel (LEVEQ-2)

Contraception | Contraception, Postcoital

Mexico
Bayer

Completed

Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia

Contraception | Menorrhagia

Finland, Ireland, France, Sweden
Bayer

Completed

A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components (INDessa)

Contraception

Germany, United Kingdom
Bayer

Completed

Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel (LEVEQ-1)

Contraception | Contraception, Postcoital

Mexico
Bayer

Completed

LCS12 Adolescent Study

Contraception

Belgium, Sweden, Austria, Finland, Netherlands, Germany, Denmark, Norway
Bayer

Completed

MiCo - Mirena or Conventional Medical Treatment for Menorrhagia

Idiopathic Menorrhagia

Croatia, South Africa, Colombia, Czech Republic, Jordan, Lebanon, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Ukraine, Venezuela, Bosnia and Herzegovina, Syrian Arab Republic, Albania
Bayer

Completed

A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years (ANALIA)

Intrauterine Devices, Medicated

Spain
Bayer
Karolinska Institutet, Stockholm, Sweden

Active, not recruiting

JAYDESS Drug Utilization Study in Sweden

Contraception

Sweden
Bayer

Completed

An Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess as Their Contraceptive Method (JULIA)

Quality of Life

Spain
University of Chicago

Terminated

Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion

Healthy

United States
Bayer

Completed

Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea

Contraception

Korea, Republic of
Planned Parenthood of the St. Louis Region and...
University of Colorado, Denver; University of Rochester; Planned Parenthood Federation... and other collaborators

Completed

Levonorgestrel Intrauterine System For Emergency Contraception (LIFE)

Pregnancy, Unplanned | Pregnancy; Accident

United States
University of Utah

Completed

RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC

Contraception

United States
Northwestern University
Society of Family Planning

Completed

Postpartum Glucose Tolerance With Levonorgesterel IUD Use in Women With Recent Gestational Diabetes

Glucose Intolerance | Type 2 Diabetes | Gestational Diabetes | Intrauterine Contraception

United States
Bayer

Completed

Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel 1.5 mg (LEVEQ-3)

Contraceptives, Postcoital

Mexico
University of Louisville

Terminated

Safety and Expulsion of Delayed Versus Immediate Postpartum Intrauterine Device Placement (IUD)

Contraception

United States
University of Pittsburgh

Completed

Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device (IUD) After Vaginal Delivery (POPI)

Contraception

United States
Walsall Healthcare NHS Trust

Unknown

RCT Novasure Versus Novasure + Mirena IUS in the Treatment of Menorrhagia

Menorrhagia

United Kingdom
Columbia University
Bayer

Completed

Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users (WESAIL)

Epilepsy | Contraception

United States
Bayer

Completed

Wellnara Post-marketing Surveillance in Japan (WELLNARA)

Osteoporosis, Postmenopausal

Japan
University of Colorado, Denver
Society of Family Planning

Completed

Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study

Contraception

United States
Bayer

Completed

Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan (ZEVALIN-SDUI)

Non-Hodgkin's Lymphoma (NHL)

Japan
Bayer

Completed

Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)

Uterine Hemorrhage

Ireland, Denmark, Norway
Spectrum Pharmaceuticals, Inc
Bayer

Completed

Zevalin Post-marketing Surveillance in Japan (ZEVALIN-DUI)

Non-Hodgkin's Lymphoma (NHL)

Japan
Bayer

Completed

A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin

Lymphoma, Follicular | Non-Hodgkin Lymphoma

Belgium
University of Chicago
University of Illinois at Chicago

Completed

Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial (MINT)

Contraception

United States
Korean Gynecologic Oncology Group

Unknown

Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006 (KGOG2006)

Endometrial Hyperplasia

Korea, Republic of
University of North Carolina, Chapel Hill
Society of Family Planning

Completed

LNG-IUS at 2 Weeks Postpartum (LNG-IUS)

Contraception | Malposition of Intrauterine Contraceptive Device

United States
United States Naval Medical Center, Portsmouth

Unknown

Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period

Contraception

United States
Fudan University
Zhejiang Cancer Hospital; Shanghai 6th People's Hospital; Shanghai Changning...

Completed

Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia

Atypical Endometrial Hyperplasia

China
Sharon Achilles

Completed

Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for Contraception (CHIC)

Genital Tract Mucosal Immunity | Genital Tract Microflora

United States

3

Subscribe